| Net cash flow from operating activities |
|
|
|
|
|
|
| Profit/(loss) for the period |
|
|
|
965 |
|
4 686 |
| Income taxes (income)/expenses |
|
28
|
|
2 486 |
|
3 263 |
| Interest income |
|
9
|
|
–29 |
|
–29 |
| Interest expenses |
|
9
|
|
2 620 |
|
2 449 |
| Profit/(loss) for the period before interest and tax |
|
|
|
6 042 |
|
10 369 |
| Depreciation, amortization and impairment |
|
8
|
|
6 417 |
|
4 329 |
| Impairment financial asset at amortized costs |
|
9
|
|
3 |
|
– |
| (Profit)/loss on sale of non-current assets |
|
7
|
|
–69 |
|
–202 |
| Share of (profit)/loss of associates |
|
13
|
|
240 |
|
723 |
| Gain recognized on FV measurement on previously held interest in an associate |
|
|
|
– |
|
–110 |
| Disposal of financial liabilities as a result of forgiveness |
|
19
|
|
– |
|
–400 |
| Changes in provisions and liabilities to employees |
|
|
|
198 |
|
185 |
| Change in fair value of biological assets |
|
11
|
|
–4 075 |
|
–4 074 |
| Other non-cash items |
|
|
|
256 |
|
13 |
| Operating cash flow before working capital changes |
|
|
|
9 012 |
|
10 833 |
| Decrease/(increase) in trade and other receivables |
|
|
|
–1 987 |
|
–1 213 |
| Decrease/(increase) in inventories |
|
|
|
–4 123 |
|
–3 263 |
| Decrease/(increase) in prepaid expenses and assets held for sale |
|
|
|
406 |
|
56 |
| Increase/(decrease) in trade payables, other liabilities and provisions |
|
|
|
3 747 |
|
1 174 |
| Income tax (paid)/received |
|
|
|
–707 |
|
–1 538 |
| Net cash flow operating activities |
|
|
|
6 348 |
|
6 049 |
| |
| Cash flow from investing activities |
| Proceeds from sale of intangible assets |
|
12
|
|
– |
|
1 471 |
| Purchase of intangible assets |
|
12
|
|
–426 |
|
–1 366 |
| Proceeds from sale of property, plant and equipment |
|
|
|
145 |
|
15 |
| Purchase of property, plant and equipment |
|
10
|
|
–4 151 |
|
–1 604 |
| Acquisition of subsidiaries, net of cash |
|
32
|
|
– |
|
–553 |
| Proceeds from disposal of other non-current assets |
|
|
|
98 |
|
– |
| Purchase of other non-current assets |
|
|
|
–1 188 |
|
–311 |
| Increase/(decrease) in recoverable taxes |
|
|
|
–2 |
|
–13 |
| Interests received |
|
9
|
|
29 |
|
29 |
| Net cash flow investing activities |
|
|
|
–5 495 |
|
–2 332 |
| |
| Cash flow from financing activities |
| Purchase of treasury shares |
|
|
|
–21 |
|
– |
| Proceeds from borrowings |
|
19
|
|
4 072 |
|
904 |
| Repayment of borrowings |
|
19
|
|
–2 486 |
|
–3 535 |
| Interests paid |
|
19
|
|
–1 295 |
|
–1 245 |
| Interests paid on lease liabilities |
|
19 / 21
|
|
–127 |
|
–142 |
| Repayment of lease liabilities |
|
19 / 21
|
|
–432 |
|
–273 |
| Net cash flow financing activities |
|
|
|
–289 |
|
–4 291 |
| |
|
|
|
|
|
|
| Net increase/(decrease) in cash and cash equivalents |
|
|
|
564 |
|
–574 |
| |
|
|
|
|
|
|
| Cash and cash equivalents, at the beginning of the year |
|
|
|
2 256 |
|
2 778 |
| Increase/(decrease) in cash and cash equivalents |
|
|
|
564 |
|
–574 |
| Translation effect on cash |
|
|
|
202 |
|
52 |
| Total Cash and cash equivalents, at the end of the year |
|
|
|
3 022 |
|
2 256 |